Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: A Pilot Study to Determine the Efficacy of a Low Carbohydrate Diet in Treatment of Adolescents With Metabolic Syndrome [NA]
A completed pilot study evaluating the efficacy of a low-carbohydrate diet in treating metabolic syndrome in adolescents.
-
CLINICAL_TRIALS research · 2015-02-02Clinical Trial Update: Central and Peripheral Blood Pressure in Treatment of Obstructive Sleep Apnea. [NA]
Clinical trial update examining the effects of treatment for obstructive sleep apnea on central and peripheral blood pressure. The current s…
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Financial Incentives for Medication Adherence [NA]
A completed clinical trial from Boston Medical Center evaluated whether financial incentives improve adherence to medications in patients wi…
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: The Effects of the Onion-Pumpkin Extract on Blood Pressure [Phase 2]
Phase 2 clinical trial evaluating onion-pumpkin extract for blood pressure has completed; the snippet does not include trial outcomes.
-
CLINICAL_TRIALS research · 2015-02-02Clinical Trial Update: Study of an Intervention to Improve Problem List Accuracy and Use [NA]
Clinical trial update from Brigham and Women's Hospital about a study to improve the accuracy and use of patients' problem lists across mult…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2015-01-30Clinical Trial Update: Kanagawa Combination Anti-hypertensive Therapy (K-CAT) [Phase 4]
Phase 4 study update on Kanagawa Combination Anti-hypertensive Therapy (K-CAT) for hypertension; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2015-01-29Clinical Trial Update: A Multicenter Study to Evaluate the ROX Anastomotic Coupler System (ACS) In Patients With Severe Hypertension [Phase 2]
A multicenter Phase 2 trial evaluating the ROX Anastomotic Coupler System (ACS) in patients with severe hypertension has been completed.
-
FDA approval · 2015-01-27FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for amlodipine besylate, confirming the approval and availability of Epic Pharma, LLC's generic prod…
-
CLINICAL_TRIALS research · 2015-01-27Clinical Trial Update: Association Between Left Ventricular Deformation and Aerobic Exercise Capacity in Untreated Arterial Hypertension
A clinical trial update investigating the association between left ventricular deformation and aerobic exercise capacity in individuals with…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Cystatin C and Uncontrolled Hypertension
A clinical trial evaluating the relationship between Cystatin C and uncontrolled hypertension has completed.
-
FDA approval · 2015-01-26FDA Approved: BREVIBLOC — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Brevibloc (esmolol hydrochloride) submitted by Baxter Healthcare Corporation.
-
FDA approval · 2015-01-26FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lotensin (benazepril hydrochloride) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Impact of a Procedure for the Information and Active Participation of the Patient in the Primary Care Prescription of Antihypertensives
A completed clinical trial evaluating a procedure to inform and actively involve patients in primary-care prescription of antihypertensives.
-
CLINICAL_TRIALS research · 2015-01-26Clinical Trial Update: Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension [Phase 3]
A Phase 3 clinical trial evaluating renal denervation for resistant hypertension in patients with end-stage renal disease; the trial status …
-
FDA approval · 2015-01-22FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Propranolol Hydrochloride from Amneal Pharmaceuticals NY LLC, indicating approval for this gener…
-
FDA approval · 2015-01-20FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA granted a supplemental approval for CAPTOPRIL (captopril) from Camber Pharmaceuticals, Inc., updating the labeling for an existing capto…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Contraceptives Containing Drospirenone and Blood Pressure [Phase 4]
Phase 4 clinical trial evaluating the impact of drospirenone-containing contraceptives on blood pressure has been completed.
-
FDA approval · 2015-01-16FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for valsartan and hydrochlorothiazide (Valsartan/HCTZ) from Aurobindo Pharma Limited, authorizing an…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Exercise in Pregnancy for Reduction of Blood Pressure in Obese Patients [NA]
This trial update reports completion of a study assessing whether an exercise program during pregnancy reduces blood pressure in obese women…
-
CLINICAL_TRIALS research · 2015-01-15Clinical Trial Update: Observational Study to Investigate Resistant Hypertension Prevalence in Korean General Hospitals
This entry reports the completion of an observational study conducted in Korean general hospitals to assess the prevalence of resistant hype…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Blueberry Consumption Improves Vascular Function and Lowers Blood Pressure in Postmenopausal Women With Pre- and Stage 1-hypertension [Phase 2]
A Phase 2 trial reports that blueberry consumption improves vascular function and lowers blood pressure in postmenopausal women with pre- an…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Efficacy of Provex CV Supplement to Reduce Inflammation Cytokines and Blood Pressure [Phase 1]
Phase 1 clinical trial results suggest Provex CV Supplement may reduce inflammation cytokines and lower blood pressure in study participants…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Angiotensin II Blockade and Inflammation in Obesity [Phase 4]
Phase 4 trial update on angiotensin II blockade and inflammation in overweight and obese individuals.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Doses of Coffee and Blood Pressure Response Post-exercise [NA]
A completed clinical trial from Federal University of Paraíba evaluating how different doses of coffee influence blood pressure responses af…
-
FDA approval · 2015-01-11FDA Approved: NIFEDIPINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for nifedipine from Chartwell RX, LLC.